ERBB2 and breast cancer: Accordingly, matrix-embedded spheroids of the HER2+ breast cancer cell line HCC1954 exhibited growth arrest following treatment with lapatinib, which was diminished with PHLDA1 knockdown (Figure 1A–C and Figure S1).